BDNF and stroke disorder: Boosting astrocytic BDNF release by administration of galectin‐1 led to significant improvement in functional recovery in an ischaemic rat model (Qu et al., 2010), and selegiline administration, proposed to increase NGF and FGF, led to modest improvement in one primary endpoint in a phase II stroke trial (Sivenius et al., 2001).